Central Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.
Department of General Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.
Aging (Albany NY). 2024 Feb 8;16(4):4052-4073. doi: 10.18632/aging.205523.
Hepatocellular carcinoma (HCC) is a prevalent liver malignancy with complex etiology and generally poor prognosis. Recently, long non-coding RNAs (lncRNAs), non-protein-coding RNA molecules exceeding 200 nucleotides, have emerged as pivotal players in HCC, influencing its initiation, progression, invasion, and metastasis. These lncRNAs modulate gene expression at epigenetic, transcriptional, and post-transcriptional levels, actively participating in the pathological and physiological processes of HCC. Understanding the intricate relationship between lncRNAs and HCC is important for improving prognosis and reducing mortality. This review summarizes advancements in elucidating the role of lncRNAs in HCC pathogenesis.
肝细胞癌(HCC)是一种常见的肝脏恶性肿瘤,其病因复杂,预后通常较差。最近,长链非编码 RNA(lncRNA),即长度超过 200 个核苷酸的非蛋白编码 RNA 分子,成为 HCC 的关键调控因子,影响其发生、发展、侵袭和转移。这些 lncRNA 通过表观遗传、转录和转录后水平调节基因表达,积极参与 HCC 的病理和生理过程。了解 lncRNA 与 HCC 之间的复杂关系对于改善预后和降低死亡率至关重要。本综述总结了阐明 lncRNA 在 HCC 发病机制中的作用的最新进展。